Fig. 1.
Levels of serum sFas in patients with liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Sera randomly obtained from patients and healthy donors were assayed for sFas levels by sandwich ELISA using DX3 and DX2 anti-Fas MoAb. Horizontal bars and dotted line represent median values and the cut-off value of sFas (3.03 ng/ml), respectively.